WHO Closer To FDA Approval For Malaria Drug
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA has been holding the world body to the same standards it uses for a regular drug review, resulting in many years of delay in bringing artesunate rectal suppositories to market - but the Anti-Infective Drugs Advisory Committee has given a partial endorsement.